DrugPatentWatch Database Preview
Patent: 9,938,273
Summary for Patent: 9,938,273
| Title: | Compounds and methods for kinase modulation, and indications therefor |
| Abstract: | Disclosed are compounds of Formula I: ##STR00001## or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein Z.sup.2, Z.sup.3, and Z.sup.5 are as described herein, compositions thereof, and uses thereof. |
| Inventor(s): | Wu; Guoxian (Foster City, CA), Wu; Jeffrey (Berkeley, CA), Chan; Katrina (Fremont, CA), Dong; Ken (Berkeley, CA), Ewing; Todd (Walnut Creek, CA), Ibrahim; Prabha N. (Mountain View, CA), Lin; Jack (Hercules, CA), Spevak; Wayne (Berkeley, CA), Zhang; Ying (Fremont, CA) |
| Assignee: | Plexxikon Inc. (Berkeley, CA) |
| Application Number: | 15/370,631 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,938,273
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech Inc | HERCEPTIN HYLECTA | trastuzumab; hyaluronidase-oysk | INJECTABLE;SUBCUTANEOUS | 761106 | 001 | 2019-02-28 | Start Trial | Plexxikon Inc. (Berkeley, CA) | 2035-12-07 | RX | search | |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 002 | 2017-06-22 | Start Trial | Plexxikon Inc. (Berkeley, CA) | 2035-12-07 | RX | Orphan | search |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 001 | 2017-06-22 | Start Trial | Plexxikon Inc. (Berkeley, CA) | 2035-12-07 | RX | Orphan | search |
| Merck Sharp Dohme | KEYTRUDA | pembrolizumab | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED POWDER | 125514 | 001 | 2014-09-04 | Start Trial | Plexxikon Inc. (Berkeley, CA) | 2035-12-07 | RX | Orphan | search |
| Genentech | PERJETA | pertuzumab | VIAL; SINGLE-USE | 125409 | 001 | 2012-06-08 | Start Trial | Plexxikon Inc. (Berkeley, CA) | 2035-12-07 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 9,938,273
| Country | Patent Number | Publication Date |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2017100201 | Jun 15, 2017 |
| United States of America | 2017158690 | Jun 08, 2017 |
| Singapore | 11201804711R | Jul 30, 2018 |
| Philippines | 12018501179 | Feb 04, 2019 |
| Mexico | 2018006856 | Aug 01, 2018 |
| >Country | >Patent Number | >Publication Date |
